High quality in vitro and in vivo studies to help prediction of therapeutic outcomes. Integration with early formulation development studies that enable more accurate scaling of results to humans.
Discovery LC-MS/MS method qualification and stand-alone PK, PD and TK sample analysis
GLP-like LC-MS/MS method validation and stand-alone PK, PD and TK sample analysis in support of IND-enabling and regulatory filing studies under USFDA and NMPA bioanalytical method validation guidelines.
Register Today! This online event "Unleashing Innovation: A New Obesogenic NASH Model with High Clinically Translational Power" translates NASH/NAFLD research to clinic with better representative data, faster.